RZRen Zhao

Ren Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ren Zhao has a total of 129 co-authors. Here are the top co-authors by number of shared publications:

  • Xiaohu Li

    Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Research Center of Clinical Medical Imaging, Anhui Province Clinical Image Quality Control Center, Hefei, China

    11 shared publications
  • Zhuoran Jia

    Department of Cardiology, National Cardiovascular Disease Regional Center for Anhui, the First Affiliated Hospital of Anhui Medical University, Hefei, China

    10 shared publications
  • Zhen Wang

    Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Research Center of Clinical Medical Imaging, Anhui Province Clinical Image Quality Control Center, Hefei, China

    9 shared publications
  • Peiyang Zheng

    Department of Cardiology, The First Affiliated Hospital of Anhui Medical University

    7 shared publications
  • Wei Deng

    Department of Radiology, Research Center of Clinical Medical Imaging, The First Affiliated Hospital of Anhui Medical University, Anhui Province Clinical Image Quality Control Center, Hefei, China

    7 shared publications
  • Yongqiang Yu

    Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Research Center of Clinical Medical Imaging, Anhui Province Clinical Image Quality Control Center, Hefei, China

    7 shared publications

Latest Publications

  • Open Access

    Cardiac and liver MRI characteristics across cumulative alcohol exposure in men with alcohol use disorder before abstinence treatment

    by Zhen Wang, Jun Chen, Yuguo Li, Zijun Zheng, Yewen Jiang, Zhanglei Li, Jun Wang, Liangjun Pang, Yongqiang Yu, Ren Zhao, et al.

  • Open Access

    Evaluating the impact of passive driver position on image consistency and repeatability in 3.0T cardiac magnetic resonance elastography

    by Jun Wang, Shutian An, Zhen Wang, Zichen Hu, Yueyue Zhang, Daiwang Jia, Yong Cheng, Yang Xiang, Ruan Fang, Peiyang Zheng, et al.

    Background: Cardiac magnetic resonance elastography (MRE) is a non-invasive technique that quantifies myocardial stiffness by tracking shear wave propagation through the heart. Shear waves are generated externally and delivered to the thorax through a passive driver placed on the chest. Passive driver position is a critical yet underexplored determinant of measurement quality. Purpose: To compare two passive driver positions in 3.0 T cardiac MRE — the apical surface projection (ASP) and the left lateral chest wall (LCW) — and to determine which yields more reliable left ventricular (LV) myocardial stiffness measurements. Methods: Twenty-three healthy volunteers (mean age 43.0 ± 17.0 years; 14 men, 9 women) underwent two cardiac MRE acquisitions, with the passive driver placed first at the ASP and then at the LCW. LV myocardial stiffness and the octahedral shear strain signal-to-noise ratio (OSS-SNR) were measured at both positions. Differences between positions were analyzed using paired t-tests with Cohen's d . Inter- and intra-observer reproducibility were assessed using intraclass correlation coefficients (ICC) and Bland–Altman analysis. Results: Myocardial stiffness was significantly lower at the ASP than at the LCW (9.0 ± 1.7 kPa vs. 14.7 ± 3.0 kPa; mean difference −5.8 kPa, 95% CI −7.2 to −4.3; P < 0.001 ; Cohen's d = − 1.73 ). OSS-SNR was significantly higher at the ASP (1.72 ± 0.48 vs. 1.25 ± 0.29; P < 0.001 ; Cohen's d = 0.85 ). At the ASP, stiffness measurements demonstrated excellent intra- and inter-observer agreement, with ICCs of 0.962 and 0.963, respectively. At the LCW, stiffness measurements demonstrated good inter-observer agreement and excellent intra-observer agreement, with ICCs of 0.839 and 0.914, respectively. Conclusion: Passive driver placement at the ASP resulted in significantly higher OSS-SNR and superior reproducibility for LV myocardial stiffness measurements compared with LCW placement. Therefore, the ASP should be considered the preferred driver position for cardiac MRE in clinical and research settings.

  • Open Access

    Association of cardiovascular-kidney-metabolic burden with recurrence after first ablation in patients with persistent atrial fibrillation

    by Peiyang Zheng, Zhuoran Jia, Huimin Wang, Xiaohe Wu, Ao Liang, Danni Li, Yinguang Fan, Xiaohu Li, Ren Zhao

    Recurrence after first radiofrequency catheter ablation remains common in patients with non-valvular persistent atrial fibrillation. Cardiovascular-kidney-

  • Open Access

    Myocardial transit time mapping by CMR: A novel potential parameter of microcirculatory dysfunction in hypertrophic cardiomyopathy with and without atrial fibrillation

    by Junlin Yang, Yong Cheng, Jinxiu Yang, Yuncheng Li, Zhen Wang, Shutian An, Jun Wang, Yongqiang Yu, Ren Zhao, Xiaohu Li

  • Open Access

    Exploring the Link Between Psoriasis and Genetic Predictors of Cardiac Magnetic Resonance Traits: A Bidirectional Mendelian Randomization Study

    by Junlin Yang, Pengzhan Yin, Shutian An, Zhanglei Li, Yewen Jiang, Jun Wang, Yongqiang Yu, Ren Zhao, Xiaohu Li

    Psoriasis is a chronic autoimmune disease characterized by systemic inflammation and skin involvement, affecting millions of individuals worldwide. However, few studies have evaluated whether psoriasis and cardiac magnetic resonance imaging (CMR) traits share a common genetic basis. This study aimed to investigate the genetic correlation and bidirectional causal relationships between psoriasis and CMR traits using Mendelian randomization (MR). We conducted a bidirectional two‐sample MR analysis to assess causal links between psoriasis and CMR traits. In the forward analysis, psoriasis was treated as the exposure and CMR traits as the outcomes; in the reverse analysis, CMR traits were used as the exposures and psoriasis as the outcome. Several MR methods were applied, including inverse variance‐weighted (IVW), MR‐Egger, weighted median, weighted mode, and simple mode. Finally, selected CMR traits were compared between patients with psoriasis and healthy controls. Psoriasis showed a causal effect on certain CMR traits, including regional peak circumferential strains (specifically, regional peak circumferential strain_13 (Ecc_AHA_13) and Ecc_AHA_14). Conversely, several CMR traits demonstrated causal effects on the risk of psoriasis, including right ventricular stroke volume (RVSV), left atrium ejection fraction (LAEF), regional peak circumferential strains (Ecc_AHA_12), and regional radial strains (regional radial strains_1(Err_AHA_1), Err_AHA_2, Err_AHA_15, and Err_global). In addition, circumferential strains (Ecc_AHA_13, Ecc_AHA_14) were higher in patients with psoriasis than in healthy controls. This research explored the genetic and causal connections between psoriasis and CMR traits, revealing the systemic influence of psoriasis on cardiovascular health.


  • Early cardioprotective effects of SGLT2i on hypertensive cardiac remodeling via STIM1/Orai1-dependent calcium signaling: beyond blood pressure control

    by Jian Wu, Zhuoran Jia, Xiaohe Wu, Yangcheng Xue, Peiyang Zheng, Huimin Wang, Ren Zhao

    The cardioprotective effects of sodium-glucose cotransporter-2 inhibitors (SGLT2i) have attracted significant attention. The calcium ion signaling pathway influences various aspects of cellular function, store-operated calcium channels (SOCCs) serve as key calcium ion channels that induce cell apoptosis and exacerbate cardiac remodeling. This study aims to investigate the effects of SGLT2i on SOCCs and its potential cardioprotective mechanisms. Sprague-Dawley (SD) rats were sequentially treated with angiotensin II (Ang II) and dapagliflozin (Dapa), randomly divided into four groups: Sham, Dapa, Ang II, and Ang II + Dapa. Blood pressure, cardiac structure and function were measured. Cardiac fibrosis evaluated using Masson's trichrome staining. The apoptosis rate of H9C2 cells was determined by flow cytometry. Protein expression levels and functional activity of SOCCs were analyzed using Western blotting, calcium imaging, and fluorescence co-localization staining. In Ang II-induced hypertension rats, no significant blood pressure lowering effect of Dapa was observed within 28 days. Notably, the absence of blood pressure reduction did not affect the timely improvement of Ang II-induced cardiac remodeling by Dapa. Ang II enhanced store-operated calcium entry (SOCE), subsequently promoting cardiomyocyte apoptosis. Dapa administration effectively suppressed this pathological process by inhibiting the overexpression and overactivation of SOCC. SGLT2i improved early cardiac remodeling induced by Ang II without relying on antihypertensive effects, mainly by inhibiting excessive activation of SOCE, which effectively attenuated Ang II-triggered cardiomyocyte apoptosis. This provides a novel therapeutic paradigm targeting impaired myocardial calcium handling in hypertensive heart disease management.


  • Exosomal miR-320c: A Novel Biomarker for Atrial Cardiomyopathy

    by Yangcheng Xue, Zhuoran Jia, Shichu Liang, Manyu Dai, Fang Liu, Jian Wu, Ren Zhao

    Early diagnosis and treatment of atrial cardiomyopathy(ACM) are crucial for patients with atrial fibrillation(AF), and further exploration of its biomarkers remains necessary. High-throughput sequencing of exosomal miRNAs was performed on blood samples from patients with persistent AF (PeAF) exhibiting mild and severe left atrial fibrosis, with supraventricular tachycardia (SVT) patients. Quantitative real-time reverse transcription polymerase chain reaction analysis validated differentially expressed miRNAs (DE miRNAs) from severe left atrial fibrosis PeAF, SVT and health controls. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses were conducted on target genes. Four exosomal DE miRNAs were identified, including miR-5106, let-7e-5p, miR-320c, and miR-382-3p. Exosomal miR-320c was down-regulated in severe left atrial fibrosis PeAF patients, while the other three miRNAs showed no significant changes. Exosomal miR-320c emerges as a potential biomarker for severe left atrial fibrosis and ACM, suggesting its suitability as a therapeutic target. Graphical Abstract Exosomal miR-320c, down-regulated in severe left atrial fibrosis, emerges as a potential biomarker for atrial cardiomyopathy and a therapeutic target.


  • Open Access

    Sodium–Glucose Cotransporter 2 Inhibitor Ameliorate Angiotensin II-Induced Hypertension and Vascular Injury by Upregulating FGF21

    by Manyu Dai, Zhuoran Jia, Huimin Wang, Peiyang Zheng, Yangcheng Xue, Ke Gong, Ren Zhao

    Clinical trials have demonstrated Sodium-glucose cotransporter 2 inhibitors (SGLT2i) antihypertensive effects, yet their underlying mechanisms remain to be fully elucidated. Fibroblast growth factor 21 (FGF21) circulating levels are associated with hypertension in humans. This study aims to investigate the roles of SGLT2i and FGF21 in improving hypertension and their potential mechanisms. A mouse model of Ang II-induced hypertension was established. Wild-type (WT) C57BL/6 mice and FGF21 knockout (FGF21−/−) mice were sequentially treated with Angiotensin II (Ang II) and dapagliflozin. Blood pressure was monitored. Cardiac structure was assessed using echocardiography. Serum FGF21 levels were measured, and the expression of fibroblast growth factor receptor 1 (FGFR1) in the thoracic aorta was quantified. Vascular pathology and oxidative stress responses were evaluated. Human aortic smooth muscle cells (HASMCs) were treated with Ang II or SGLT2i, and FGF21 was knocked down in HASMCs to explore its mechanism of action. SGLT2i increased the expression of FGF21 and FGFR. SGLT2i improved Ang II-induced systolic blood pressure elevation, myocardial hypertrophy, vascular wall thickening, fibrosis, and oxidative stress in WT mice. These protective effects were reduced in FGF21−/− mice. Knockdown of FGF21 in HASMCs abolished the SGLT2i-induced upregulation of antioxidant markers and the downregulation of TGF-β and fibrosis-related proteins. SGLT2i-mediated blood pressure-lowering and vascular protective effects are primarily achieved through the activation of the FGF21/FGFR1. Graphical Abstract


  • Open Access

    Arachidonic acid is involved in high-salt diet-induced coronary remodeling through stimulation of the IRE1α/XBP1s/RUNX2/OPN signaling cascade

    by Zhuoran Jia, Jian Wu, Fang Liu, Huimin Wang, Peiyang Zheng, Bing Shen, Ren Zhao

    The impact of a high-salt (HS) diet on metabolic disturbances in individuals with coronary heart disease remains unclear. The arachidonic acid (AA) metabolic pathway is closely linked to the development of cardiometabolic diseases and atherosclerotic cardiovascular diseases. Furthermore, endoplasmic reticulum stress (ERS) has emerged as a major contributor to cardiometabolic diseases. AA-related inflammation and ERS are hypothesized to play a role in HS diet-induced coronary remodeling. Rats were subjected to an HS diet for 4 weeks, and the serum concentration of AA was measured via enzyme-linked immunosorbent assay. Immunofluorescence staining and vascular tension measurements were conducted on coronary arteries. In addition, AA-stimulated coronary artery smooth muscle cells (CASMCs) were treated with ERS inhibitors to explore the underlying pathway involved. Increased susceptibility to myocardial infarction in the HS diet-fed rats was accompanied by increased serum AA concentrations and increased expression of the key AA metabolic enzyme cyclooxygenase-2 (COX-2). AA incubation weakened the contraction of denuded coronary arteries, reduced the expression of contraction markers, and increased the fluorescence intensity of synthetic and ERS response markers in coronary arteries. Further investigation of CASMCs revealed that AA-induced phenotypic transformation was mediated via the ERS pathway. ERS and AA were found to be stimulated in CASMCs following an HS diet. AA triggers an ERS response through COX-2 catalysis, and the downstream inositol requiring enzyme 1 - X-box binding protein-1 - osteopontin pathway may contribute to the AA-induced phenotypic transformation of CASMCs, resulting in dysfunctional coronary tension. This study may provide potential therapeutic targets for cardiovascular diseases associated with excessive AA-derived ERS.